OTC switch in one country should spark "debate" in others -- European assoc. director.
This article was originally published in The Tan Sheet
Executive Summary
OTC SWITCH IN ONE COUNTRY SHOULD SPARK "DEBATE" IN OTHERS, European Proprietary Medicines Manufacturers Association Director Hubertus Cranz asserted during an Oct. 30 session of the World Federation of Proprietary Medicine Manufacturers 12th general assembly in Toronto, Ontario. While a switch in one country "cannot immediately force other countries" to take similar action, it should "stimulate a debate" because it suggests that "comprehensive scientific material" supporting nonprescription status is available, he said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: